logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sudarshan Paramsothy

concord repatriation general hospital
H指数:29
被引数:5,002

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ustekinumab has the highest persistence in Crohn's Disease, vedolizumab has the highest persistence in Ulcerative Colitis, and persistence declines from first- to fourth-line therapy

乌司奴单抗在克罗恩病中具有最高的持续率，维得利珠单抗在溃疡性结肠炎中具有最高的持续率，且持续率从一线治疗到四线治疗逐渐下降

Journal of Crohns & Colitis
IF8.7
2026-01-010
PRE
Gu, B.; Chetwood, J.; Pudipeddi, A.; Yau, Y.; Kariyawasam, V; Paramsothy, S.; Leong, R. W.
Combination therapy with an immunomodulator improves persistence of anti-tumour necrosis factor agents but not vedolizumab or ustekinumab in Inflammatory Bowel Disease, with improved persistence seen with longer duration of initial combination therapy before de-escalation

免疫调节剂联合疗法可提高炎症性肠病患者中抗肿瘤坏死因子药物的持续性，但对 vedolizumab 或 ustekinumab 无影响，且初始联合疗法持续时间越长，在减量前的持续性越好

Journal of Crohns & Colitis
IF8.7
2026-01-010
PRE
Gu, B.; Chetwood, J. D.; Pudipeddi, A.; Yau, Y.; Kariyawasam, V; Paramsothy, S.; Leong, R. W.
Randomised controlled trial of continued intravenous versus switching to subcutaneous infliximab in inflammatory bowel disease: the Subcutaneous Infliximab Switch Study (SISS).

随机对照试验：炎症性肠病患者持续静脉注射与转为皮下注射英夫利昔单抗的比较——皮下注射英夫利昔单抗转换研究（SISS）

Journal of Crohns & Colitis
IF8.7
2026-01-010
PRE
Chetwood, J.; Redmond, D.; Kermeen, M.; Kariyawasam, V; Thin, L.; Lightowler, D.; Corte, C.; Ding, N. J. S.; Ward, M. G.; Little, R.; Kwan, V; De Cruz, P.; Lee, L. H.; Duong, T. A.; Lee, E.; Menon, S.; Khaing, M. M.; Beswick, L.; Lagumbay, L.; Walker, T.; Paramsothy, S.; Leong, R.
Pregnancy and Infant Outcomes After In Utero Exposure to JAK Inhibitors in Inflammatory Bowel Disease: A Global Multicenter Cohort Study

炎症性肠病患者在子宫内暴露于JAK抑制剂后的妊娠和婴儿结局：一项全球多中心队列研究

Journal of Crohns & Colitis
IF8.7
2026-01-010
PRE
Julsgaard, M.; Baunwall, S. M.; Seow, C.; Duricova, D.; Kane, S.; Zacharias, N.; Leong, R.; Cremer, A.; Kok, K.; Kagramanova, A., V; Pipek, B.; Candido, K.; Cooney, R.; Filip, R.; Kiudelis, V; Konecny, M.; Paramsothy, S.; Pugliese, D.; Oliveira Santana Silva, G.; Savarino, E., V; Smolovic, B.; Vieujean, S.; Wei, S. C.; Mahadevan, U.
Ustekinumab and vedolizumab in the treatment of fistulising Crohn's disease: a propensity score-matched analysis from the prospective Persistence Australian National Inflammatory Bowel Disease Cohort (PANIC5) study

乌司奴单抗和维多利珠单抗在瘘管性克罗恩病治疗中的应用：来自前瞻性Persistence澳大利亚国家炎症性肠病队列（PANIC5）研究的倾向性评分匹配分析

Journal of Crohns & Colitis
IF8.7
2026-01-010
PRE
Chetwood, J.; Paramsothy, S.; Leong, R.
Early tumour necrosis factor inhibitor initiation is associated with increased persistence in Crohn's Disease but not Ulcerative Colitis, whereas early ustekinumab, vedolizumab and tofacitinib did not improve persistence

早期肿瘤坏死因子抑制剂启动与克罗恩病中持续性的增加相关，但与溃疡性结肠炎无关，而早期使用ustekinumab、vedolizumab和tofacitinib并未改善持续性

Journal of Crohns & Colitis
IF8.7
2026-01-010
PRE
Gu, B.; Chetwood, J.; Pudipeddi, A.; Yau, Y.; Kariyawasam, V; Paramsothy, S.; Leong, R. W.
Multiple advanced therapies in combination for the treatment of inflammatory bowel disease - a bi-national registry

多种先进疗法联合治疗炎症性肠病——一项跨国登记研究

Journal of Crohns & Colitis
IF8.7
2026-01-010
PRE
Chetwood, J.; Le, P. H.; Wei, S. C.; Wu, H. Y.; Corte, C.; Lightowler, D.; Gilmore, R.; Chin, S.; Garg, M.; Kashkooli, S. Bahmani; Xu, Z.; Wright, E. K.; Sparrow, M. P.; O'donnell, J.; Lewindon, P.; Subramanian, K.; Fu, J. Huang; Moore, G. T.; Subhaharan, D.; Mohsen, W.; Tan, Z.; Thin, L.; Ghali, M.; Ghaly, S.; De Cruz, P.; Lo, S. W.; Paramsothy, S.; Leong, R.
Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases

亚太胃肠病学协会关于炎症性肠病组织病理学评估的共识声明

Therapeutic Advances in Gastroenterology
IF3.4
2025-08-190
OA
Rupert W. Leong; Thanaboon Chaemsupaphan; Huiyu Lin; Wee Chian Lim; Choon Jin Ooi; John D. Chetwood; Ren Mao; Hsin Yun Wu; Shu Chen Wei; Govind Makharia; Vineet Ahuja; Rupa Banerjee; Raja Atreya; Julajak Limsrivilai; Satimai Aniwan; Pises Pisespongsa; Ida Hilmi; Raja Affendi Raja Ali; Wai Keung Leung; Siew C. Ng; Byong Duk Ye; Taku Kobayashi; Katsuyoshi Matsuoka; Cora Chau; Anapat Sanpavat; Chia-Tung Shun; Pavitratha Puspanathan; Richard B. Gearry; Silvio Danese; Christopher Ma; Aviv Pudipeddi; Sudarshan Paramsothy
Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study
JOURNAL OF CROHNS & COLITIS
IF8.7
2025-01-220
PRE
Jayawardana, T.; Little, R. D.; Zhang, F.; Koentgen, S.; Wu, N.; Houshyar, Y.; Tavakoli, P.; Boussioutas, A.; Ward, M. G.; Sparrow, M. P.; Gibson, P. R.; Ghaly, S.; Corte, C.; Talley, N. J.; Leach, S.; Lemberg, D.; Dutt, S.; Paramsothy, S.; Leong, R.; Connor, S. J.; Hold, G.; Australia IBD Microbiome AIM Study
Association of gut microbiota changes and disease activity in patients with Crohn's disease and ulcerative colitis: baseline data from the Australian IBD Microbiome study
JOURNAL OF CROHNS & COLITIS
IF8.7
2025-01-220
PRE
Little, R.; Jayawardana, T.; Zhang, F.; Houshyar, Y.; Koentgen, S.; Wu, N.; Ellepola, A.; Tavakoli, P.; Chung, A.; Ho, A.; Read, S.; Boussioutas, A.; Ward, M.; Sparrow, M.; Gibson, P.; Ghaly, S.; Corte, C.; Talley, N.; Leach, S.; Lemberg, D.; Dutt, S.; Paramsothy, S.; Leong, R.; Connor, S.; Hold, G.

研究方向

暂未获取到该数据
R
Rupert W. Leong
H 指数:67论文数:635被引数:1.8万
N
Nadeem O. Kaakoush
H 指数:49论文数:219被引数:1.7万
A
Aviv Pudipeddi
H 指数:10论文数:73被引数:323
T
Thomas J. Borody
H 指数:55论文数:297被引数:1.5万
S
Susan J. Connor
H 指数:31论文数:270被引数:5,296
M
Michael A. Kamm
H 指数:129论文数:791被引数:5.9万
C
Craig Haifer
H 指数:13论文数:56被引数:754
C
Crispin Corte
H 指数:16论文数:114被引数:1,035
S
Simon Ghaly
H 指数:15论文数:89被引数:1,255
H
Hazel M. Mitchell
H 指数:57论文数:193被引数:1.2万